Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PAVmed Inc.
  6. Company
    PAVM   US70387R1068

PAVMED INC.

(PAVM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo PAVmed Inc.
PAVmed Inc. is a multi-product, commercial-stage technology medical device company. The Company has four operating divisions. GI Health division includes EsoGuard, EsoCheck and EsoCure. EsoGuard and EsoCheck have been developed to provide non-invasive, patient-friendly screening test for the early detection of adenocarcinoma of the esophagus (EAC) and Barrett's Esophagus (BE), including dysplasia and related pre-cursors to EAC in patients with chronic gastroesophageal reflux (GERD). EsoCure is in development as an Esophageal Ablation Device with the intent to allow a clinician to treat dysplastic BE before it can progress to EAC. Minimally Invasive Interventions division offers CarpX, a minimally invasive surgical device for carpal tunnel syndrome. Infusion Therapy division includes PortIO, which is an implantable, intraosseous vascular access device, and NextFlo, which is a disposable, infusion platform technology that includes intravenous infusion sets and disposable infusion pumps.

Number of employees : 25 people.
Managers
Name Title Age Since
Lishan Aklog, Dr. Chairman & Chief Executive Officer 55 2014
Dennis M. McGrath President, Chief Financial Officer & Secretary 64 2019
Brian J. deGuzman, Dr. Chief Medical Officer & Executive Vice President 57 2016
Michael J. Glennon Vice Chairman 55 2014
Ronald M. Sparks Independent Director 66 2015
James Leslie Cox, Dr. Independent Director 78 2015
Debra J. White Independent Director 58 2021
Adrian Kiel Miller Vice President-Investor Relations - 2022
Shaun M. O’Neil Chief Commercial Officer - 2018
James Mitchell, Dr. Vice President-Digital Health - 2021
Members of the board
Name Title Age Since
Lishan Aklog, Dr. Chairman & Chief Executive Officer 55 2014
Michael J. Glennon Vice Chairman 55 2014
Ronald M. Sparks Independent Director 66 2015
James Leslie Cox, Dr. Independent Director 78 2015
Debra J. White Independent Director 58 2021
Tim Baxter Director 60 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 87,934,511 78,717,739 89.5% 0 0.0% 89.5%
Stock B 0 1,091,448 0 0.0% 0 0.0%
Shareholders
NameEquities%
Lishan Aklog 5,717,066 6.50%
The Vanguard Group, Inc. 4,009,107 4.56%
SSgA Funds Management, Inc. 2,654,358 3.02%
Matthew Ivan Sirovich 2,504,244 2.85%
BlackRock Fund Advisors 1,786,850 2.03%
Fidelity Management & Research Co. LLC 1,413,201 1.61%
Sabby Capital LLC 1,398,850 1.59%
Geode Capital Management LLC 1,217,618 1.38%
Dennis M. McGrath 955,462 1.09%
EAM Investors LLC 769,387 0.87%
Holdings
NameEquities%Valuation
LUCID DIAGNOSTICS INC. (LUCD) 27,927,190 75.9% 149,969,010 USD
Company contact information
PAVmed, Inc.
One Grand Central Place
60 East 42nd Street
Suite 4600
New York, NY 10165

Phone : +1.212.949.4319
Web : http://www.pavmed.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of PAVmed Inc.
Sector Other Advanced Medical Equipment & Technology
1st jan.Capi. (M$)
PAVMED INC.-41.87%133
THERMO FISHER SCIENTIFIC-17.01%221 810
DANAHER CORPORATION-17.94%190 628
INTUITIVE SURGICAL, INC.-26.87%94 475
SIEMENS HEALTHINEERS AG-12.06%73 622
EDWARDS LIFESCIENCES CORPORATION-21.30%67 821
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.-14.39%64 004
BOSTON SCIENTIFIC CORPORATION1.32%61 332
ILLUMINA, INC.-14.74%51 857
AGILENT TECHNOLOGIES, INC.-17.26%40 320
RESMED INC.-13.66%33 781
PHILIPS NV-11.29%28 519
OLYMPUS CORPORATION-7.59%27 515
CERNER CORPORATION-1.88%26 694
PERKINELMER, INC.-18.51%21 009
WATERS CORPORATION-17.20%18 830
HOLOGIC, INC.-11.08%17 144
CARL ZEISS MEDITEC AG-24.70%14 078
ABIOMED, INC.-17.27%13 519
BRUKER CORPORATION-24.90%9 750
GN STORE NORD A/S-3.89%7 653